Stona-s Capsule
NDC Package 49873-113-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Stona-s (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride) capsules is uses■temporarily relieves these symptoms due to a cold, the flu, or hay fever:     ■minor aches and pains  ■headache  ■sore throat  ■nasal congestion     ■runny nose  ■sinus congestion and pressure     ■cough due to minor throat and bronchial irritation     ■sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever ■temporarily reduces fever. This formulation utilizes a capsule delivery system. Marketed by Sato Pharmaceutical Co., Ltd., this product is identified by NDC 49873-113 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
49873-113-01
Package Description
1 BOTTLE in 1 CARTON / 24 CAPSULE in 1 BOTTLE
Product Code
49873-113
11-Digit Billing Format
49873011301
RxNorm Crosswalk
  • RxCUI: 1242747 - acetaminophen 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Capsule
  • RxCUI: 1242747 - acetaminophen 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule
  • RxCUI: 1242747 - APAP 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule

Clinical Specifications

Proprietary Name
Stona-s
Non-Proprietary Name
Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses■temporarily relieves these symptoms due to a cold, the flu, or hay fever:     ■minor aches and pains  ■headache  ■sore throat  ■nasal congestion     ■runny nose  ■sinus congestion and pressure     ■cough due to minor throat and bronchial irritation     ■sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever ■temporarily reduces fever

Regulatory & Marketing

Labeler Name
Sato Pharmaceutical Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-27-2004
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49873-113-01 identifies a specific commercial package of 1 bottle in 1 carton / 24 capsule in 1 bottle of Stona-s, a human over the counter drug labeled by Sato Pharmaceutical Co., Ltd.. This capsule is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sato Pharmaceutical Co., Ltd. on September 27, 2004. The current certification is valid through December 31, 2026.

How is this Sato Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49873011301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49873-113-01
11-Digit CMS (5-4-2)
49873-0113-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.